Mail

UK markets closed

FTSE 100
8,433.76
+261.61(+3.20%)
FTSE 250
20,645.38
+593.08(+2.96%)
AIM
789.87
+21.76(+2.83%)
GBP/EUR
1.1617
-0.0035(-0.30%)
GBP/USD
1.2521
-0.0026(-0.21%)
Bitcoin GBP
48,958.67
+230.81(+0.47%)

Family-run Stilton maker on Brexit and copycats

'We want people to eat more cheese for breakfast'

Foghorn Therapeutics Inc. (FHTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

5.56

-0.38

(-6.40%)

At close: 04:00PM EDT

5.46

-0.10

(-1.80%)

After hours:

07:50PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	236.78M
Enterprise value	73.09M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	6.91
Price/book (mrq)	N/A
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	3.15
52-week change ³	-13.80%
S&P500 52-week change ³	26.27%
52-week high ³	9.97
52-week low ³	2.70
50-day moving average ³	6.32
200-day moving average ³	5.75

Share statistics

Avg vol (3-month) ³	100.57k
Avg vol (10-day) ³	59.6k
Shares outstanding ⁵	42.59M
Implied shares outstanding ⁶	42.59M
Float ⁸	21.37M
% held by insiders ¹	24.78%
% held by institutions ¹	62.29%
Shares short (30 Apr 2024) ⁴	1.32M
Short ratio (30 Apr 2024) ⁴	17.41
Short % of float (30 Apr 2024) ⁴	4.53%
Short % of shares outstanding (30 Apr 2024) ⁴	3.09%
Shares short (prior month 28 Mar 2024) ⁴	1.19M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	-274.23%
Operating margin (ttm)	-558.30%

Management effectiveness

Return on assets (ttm)	-20.46%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	33.9M
Revenue per share (ttm)	0.81
Quarterly revenue growth (yoy)	-4.90%
Gross profit (ttm)	N/A
EBITDA	-99.36M
Net income avi to common (ttm)	-92.95M
Diluted EPS (ttm)	-2.20
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	206.66M
Total cash per share (mrq)	4.85
Total debt (mrq)	42.98M
Total debt/equity (mrq)	N/A
Current ratio (mrq)	4.06
Book value per share (mrq)	-2.29

Cash flow statement

Operating cash flow (ttm)	-116.27M
Levered free cash flow (ttm)	-52.85M